Bionano Genomics (BNGO) Common Equity (2017 - 2026)
Bionano Genomics (BNGO) posted Common Equity of $37.5 million for Q1 2026, down 15.67% sequentially from $44.4 million in Q4 2025, and down 22.26% YoY from $48.2 million in Q1 2025.
Bionano Genomics (BNGO) Common Equity (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Common Equity for 10 years, with the latest figure at $37.5 million in Q1 2026.
- Quarterly Common Equity fell 22.26% year-over-year to $37.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.5 million (down 22.26% YoY) and the FY2025 annual result came in at $44.4 million, up 25.58% from the prior year.
- Common Equity fell to $37.5 million in Q1 2026 per BNGO's latest filing, from $44.4 million in the prior quarter.
- Over five years, Common Equity peaked at $311.2 million in Q1 2022 and troughed at $35.4 million in Q4 2024.
- A 5-year average of $133.0 million and a median of $82.8 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2024 and 2025: Common Equity tumbled 64.24% in 2024, then grew 25.58% in 2025.
- Over 5 years, Common Equity stood at $249.4 million in 2022, then sank by 61.44% to $96.2 million in 2023, then slumped by 63.21% to $35.4 million in 2024, then advanced by 25.58% to $44.4 million in 2025, then declined by 15.67% to $37.5 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $37.5 million, $44.4 million, and $49.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | 31.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.61 Mn |
| Mar 31, 2026 | 37.46 Mn |
| Dec 31, 2025 | 44.42 Mn |
| Sep 30, 2025 | 49.80 Mn |
| Jun 30, 2025 | 45.37 Mn |
| Mar 31, 2025 | 48.19 Mn |
| Dec 31, 2024 | 35.38 Mn |
| Sep 30, 2024 | 48.86 Mn |
| Jun 30, 2024 | 80.34 Mn |
| Mar 31, 2024 | 82.77 Mn |
| Dec 31, 2023 | 96.16 Mn |
| Sep 30, 2023 | 119.00 Mn |
| Jun 30, 2023 | 214.76 Mn |
| Mar 31, 2023 | 231.49 Mn |
| Dec 31, 2022 | 249.40 Mn |
| Sep 30, 2022 | 281.74 Mn |
| Jun 30, 2022 | 284.73 Mn |
| Mar 31, 2022 | 311.19 Mn |
| Dec 31, 2021 | 337.12 Mn |
| Sep 30, 2021 | 341.57 Mn |